Morgan Stanley analyst Kallum Titchmarsh initiated coverage of Mettler-Toledo (MTD) with an Equal Weight rating and $1,550 price target Life Science Tools and Diagnostics end market bright spots are beginning to emerge and the firm sees “plenty of catalysts” in the pipeline across its coverage, adding that it sees “lots to like in the space entering 2026.” However, a recent industry valuation spike in the second half of the year leaves multiples in “a fair place,” so the firm starts the group with an In-Line industry view, the analyst tells investors. Among the group, the analyst identifies Danaher (DHR) as Top Pick.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTD:
- Mettler-Toledo price target raised to $1,500 from $1,450 at BofA
- Mettler-Toledo price target raised to $1,400 from $1,200 at Wells Fargo
- Mettler-Toledo price target raised to $1,600 from $1,450 at Stifel
- Mettler-Toledo price target raised to $1,444 from $1,342 at Baird
- Mettler-Toledo price target raised to $1,700 from $1,600 at Citi
